Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    12540794 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Procedure: Hepatic arterial infusion chemotherapy;   Drug: Oxaliplatin , fluorouracil, and leucovorin
2 Recruiting Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Transarterial Radioembolization;   Procedure: Transarterial Chemoembolization using drug-eluting beads
3 Unknown  TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
4 Recruiting Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
Condition: Liver Cancer
Intervention: Procedure: Blood draw
5 Unknown  Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Hepatectomy;   Procedure: TACE combined with local regional therapies without hepatectomy
6 Completed Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Procedure: Transarterial chemoembolization (TACE)

Indicates status has not been verified in more than two years